ABOUT THE SUMMIT
The Virtual Investing in Cures Summit (ICS) convenes key stakeholders of the Foundation Fighting Blindness and RD Fund to learn from the world’s leading industry, clinical and retinal science innovators poised to take emerging therapies across the finish line.
Monday through Friday sessions will be one-hour each day and Saturday will have three one-hour sessions. Join this week-long, exclusive virtual event where discussion about preclinical and clinical assets focused on retinal disease conditions will be shared.
- Get a sneak peek with our researchers as they perform sight-saving laboratory techniques during our virtual laboratory experiences. Each experience will be followed by live Q&A with a research scientist.
- Tour one of our partner’s, Blueprint Genetics, laboratories and get updates on the Foundation’s Open Access Genetic Testing Program.
- Join CEO, Ben Yerxa, PhD, as he sits down with stakeholders from all sectors of the ecosystem to discuss advancements in the retinal field.
- Live sessions will be recorded and available on demand, including additional videos that will be posted to the event site on a daily basis.
SPEAKERS
Tero-Pekka Alastalo, MD, PhD
Executive Medical Director and Co-founder, Blueprint Genetics
Kapil Bharti, PhD
Senior Investigator NEI, NIH
Stéphane Boissel
CEO
SparingVision
Laura Manfre
Director, HCLD, Hewlett Packard and Co-founder, Sofia Sees Hope
Board Director
Foundation Fighting Blindness
Patrick Ritschel, MBA
CEO
Atsena Therapeutics
Glenn Sblendorio, MBA
CEO and President
Iveric Bio
Ilyas Washington, PhD
Co-founder
Alkeus Pharmaceuticals
Deniz Dalkara, PhD
INSERM researcher Paris Vision Institute
Denny Moyer
Founding Member and CEO Ensight Skills Center for Low Vision Rehabilitation
Wiley Chambers, MD
Director, Division of Ophthalmology, Office of Specialty Medicine, Office of New Drugs Food and Drug Administration (FDA)
Richard Awdeh, MD
CEO and Founder
CheckedUp
Michelle Glaze
Associate Director, Professional Outreach
Foundation Fighting Blindness
Christelle Monville, PhD
Professor, Evry’s University
Team Leader, Istem lab (France)
Glen Prusky, PhD
Professor in the Department of Physiology and Biophysics
Weill Cornell Medicine
Todd Durham, PhD
VP, Clinical & Outcomes Research
Foundation Fighting Blindness
Rob Collin, PhD
Professor, Molecular Therapies for IRDs
Radboud University Medical Center
David Brint
Chairman
Foundation Fighting Blindness
Warren Thaler
Chairman, RD Fund
Board Director
Foundation Fighting Blindness
Evan Mittman
Board Director
Foundation Fighting Blindness
Magali Taiel, MD
Chief Medical Officer
GenSight-Biologics
Tarran Pierfelice, PhD , MBA
Business Head of National Gene Therapy Franchise
Resilience
Walter Strapps, PhD
Chief Scientific Officer
Gemini
John Corneille, JD
Director, Legacy Giving
Foundation Fighting Blindness
Steve Pakola, MD
Chief Medical Officer
REGENXBIO
Kevin Bitterman, PhD
Partner
Atlas Ventures
Thomas Ciulla, MD, MBA
Chief Medical Officer and Chief Development Officer
Clearside Biomedical
Robert Fishman, MD
Chief Medical Officer
4DMT
Halden Conner
President and CEO
Gabrielle DeBartolomeo
Clinical Trial Scientist
SPONSORS
Venture Partner
Seed Partner
Angel Partner
Seed Partner
WHEN
WHERE
